Email Us
Call Us
Most oncology therapeutics reach patients as part of a combination, and combination behavior is not predictable from single-agent activity. Two compounds of comparable potency can be synergistic, additive, or frankly antagonistic, and the outcome frequently depends on the order in which they are given. Establishing this in culture costs a fraction of discovering it in an animal study, and avoids the most expensive form of negative result: a combination arm that fails because the agents interfere with each other.
Altogen Labs conducts combination and synergy studies in monolayer, three-dimensional, and organoid formats, with designs and analysis methods specified before the experiment runs. To discuss a combination program, request a quote.
Matrix design
A combination tested at a single ratio provides one point on a surface and cannot establish interaction. Matrix designs titrate both agents across a concentration grid, generating a response surface from which interaction is quantified across the full range rather than asserted from one pairing.
The grid is centered on concentrations relevant to each agent individually, typically spanning below and above the single-agent potency of each, since interaction frequently appears at concentrations where one agent alone has little effect and would be missed by a grid centered on active concentrations only.
Quantifying interaction
Synergy is a quantitative claim requiring a reference model, and different models can classify the same data differently. The model used is specified before the experiment rather than selected after the data are seen, because choosing the model that produces the most favorable classification is not an analysis.
Established reference models based on dose additivity and on independent action are both in use, and reporting against more than one is often appropriate, with disagreement between them stated rather than resolved silently. The magnitude of any interaction is reported alongside its classification, since a statistically detectable but small deviation from additivity rarely has therapeutic consequence.
Sequence dependence
Where one agent modulates a pathway on which the other depends, order of administration alters the outcome. A compound arresting cells in a particular cell cycle phase can protect them from an agent requiring active division, producing antagonism when given first and synergy when given second.
Sequence-dependent designs test both orders alongside simultaneous administration. Where a combination is intended for clinical use in a particular sequence, testing only simultaneous exposure leaves the relevant question unanswered.
Applied examples
Combination triage. Three candidate partners for a targeted agent are tested in matrix format, identifying one synergistic, one additive, and one antagonistic pairing, so only the synergistic combination consumes an in vivo arm.
Sequence effect. A cell cycle inhibitor and a cytotoxic agent are tested in both orders and simultaneously, establishing that the cytotoxic agent must precede the inhibitor for benefit.
Resistance context. A combination is tested against a parental line and a resistant derivative, establishing whether the partner restores sensitivity in the resistant setting.
From culture to in vivo combination studies
Combinations demonstrating synergy in culture are candidates for in vivo evaluation, with the concentration ratio producing the strongest interaction informing the dose ratio taken forward. Interaction observed in culture does not guarantee benefit in vivo, since exposure, distribution, and tolerability of the combination all bear on the outcome, and tolerability of two agents together is assessed rather than assumed from single-agent data.
Design specification and reporting
Concentration grid, replicate structure, readout, reference model, and acceptance criteria are specified before the experiment runs. Single-agent arms are included in every experiment rather than taken from a previous one, since combination classification depends on the single-agent response measured under identical conditions. Reports include the full response surface, the interaction metric with its reference model named, single-agent curves from the same experiment, and raw data.
Send the agents, indication, and intended clinical sequence, or request a quote.